Anti-C5a [Fab 31]
Ab00991-10.6
ApplicationsELISA
Product group Antibodies
ReactivityHuman
TargetC5
Overview
- SupplierAbsolute Antibody
- Product NameAnti-C5a [Fab 31]
- Delivery Days Customer7
- Antibody SpecificityFab 31 recognises both C5 and C5a.
- ApplicationsELISA
- Applications SupplierELISA
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDFab 31
- Gene ID727
- Target nameC5
- Target descriptioncomplement C5
- Target synonymsanaphylatoxin C5a analog; C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4; C5a; C5a anaphylatoxin; C5b; C5D; complement C5; complement component 5; CPAMD4; ECLZB; prepro-C5
- HostHuman
- Protein IDP01031
- Protein NameComplement C5
- Scientific DescriptionThis chimeric human antibody was made using the variable domain sequences of the original Mouse Fab format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Reactivity SupplierHuman
- Reactivity Supplier NoteA panel of mAbs against the activated complement component C5a was obtained from a filamentous phage M13-Fab display library generated from mice immunized with human rC5a. Fabs isolated from the library after iterative selection against rC5a bound to both rC5a and purified C5. To isolate Fabs specific for neoepitopes expressed on C5a but not on the native complement component C5, the library was rescreened in a competitive manner. The phage Fab library was first incubated with immobilized C5 to deplete C5 reactive Fabs. The C5 nonadherent phage were then incubated with immobilized rC5a in the presence of soluble C5. Bound phage were eluted and subjected to two additional cycles of subtraction with immobilized C5 and selection with immobilized rC5a in the presence of soluble C5. After three cycles of this competitive biopanning, Fabs reactive with rC5a were isolated.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203